March 3, 2007
Pharmacosmos participates in the World Congress of Nephrology (WCN) 2007. The congress is held in Rio de Janeiro, Brazil, during the period April 20-25, 2007.
For additional information about the World Congress of Nephrology 2007, please visit the World Congress of Nephrology Website.
About Pharmacosmos A/S
Pharmacosmos develops and markets
medicines for the treatment of iron deficiency. A research-based
company, its ongoing R&D programme focuses on improving the
treatment options for healthcare professionals, patients suffering
from iron deficiency and veterinary treatments. .
Pharmacosmos is a family-owned
Danish company and operates in more than 50 countries across
Europe, the Americas and Asia. Its facilities are approved by both
the Danish Medicines Agency and the US Food & Drug